New drug CS-1103 takes first step toward fighting meth abuse
Knowledge-focused
Completed
This early-phase trial tested the safety of a new drug called CS-1103 in 32 healthy adults. Researchers gave single doses by IV to see if it causes side effects and how the body processes it. The goal is to gather basic safety information before testing it in people with methamph…
Phase: PHASE1 • Sponsor: Clear Scientific, Inc. • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:00 UTC